Title	Publication Date	Language	Citations
African swine fever	2019/05/01	English	304
Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research	2013/12/01	English	297
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)	2010/01/01	English	294
Antiviral activities of type I interferons to SARS-CoV-2 infection	2020/07/01	English	284
Accessory proteins of SARS-CoV and other coronaviruses	2014/09/01	English	283
Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro	2009/08/01	English	279
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern	2022/02/01	English	278
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus	2016/01/01	English	268
Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS	2014/01/01	English	262
Influenza virus resistance to neuraminidase inhibitors	2013/05/01	English	262
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV	2017/01/01	English	262
Inhibition of the infectivity of influenza virus by tea polyphenols	1993/08/01	English	259
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine	2010/01/01	English	258
Chikungunya: Evolutionary history and recent epidemic spread	2015/08/01	English	258
Ten years of dengue drug discovery: Progress and prospects	2013/11/01	English	257
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses	2018/05/01	English	253
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance	2010/01/01	English	232
Structure and functionality in flavivirus NS-proteins: Perspectives for drug design	2010/08/01	English	231
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses	2013/10/01	English	231
Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro	1987/07/01	English	228
A potential role for integrins in host cell entry by SARS-CoV-2	2020/05/01	English	224
In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit	2018/12/01	English	224
Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines	2019/04/01	English	222
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts	2018/11/01	English	217
Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding	2017/06/01	English	215
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites	2020/06/01	English	212
Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin	2013/09/01	English	211
Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol	2009/02/01	English	209
Strategies for development of dengue virus inhibitors	2010/03/01	English	207
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa	2009/07/01	English	206